Analyst Research: Alnylam Pharmaceuticals Inc (ALNY.O)

ALNY.O on Nasdaq

56.96USD
11 Feb 2016
Change (% chg)

-- (--)
Prev Close
$56.96
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
963,557
52-wk High
$140.00
52-wk Low
$53.26

Search Stocks
Name Age Since Current Position

Michael Bonney

57 2016 Chairman of the Board

Barry Greene

51 2007 President, Chief Operating Officer

John Maraganore

52 2007 Chief Executive Officer, Director

Akshay Vaishnaw

52 2014 Executive Vice President - Research and Development ,Chief Medical Officer

Laurie Keating

60 2014 Senior Vice President - General Counsel, Secretary
Search Stocks